NASDAQ: KLTO
Klotho Neurosciences Inc Stock Ownership - Who owns Klotho Neurosciences?

Insider buying vs selling

Have Klotho Neurosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KLTO insiders and whales buy or sell their stock.

KLTO Shareholders

What type of owners hold Klotho Neurosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Joseph Sinkule7.90%4,846,700$2.30MInsider
Redwoods Capital LLC5.08%3,115,000$1.48MInsider
Chardan Capital Markets LLC2.09%1,284,364$610.07kInsider
Jeff Leblanc1.50%920,342$437.16kInsider
Samuel M. Zentman1.20%736,440$349.81kInsider
Vanguard Group Inc0.96%588,342$279.46kInstitution
Shalom Hirschman0.91%558,873$265.46kInsider
Geode Capital Management LLC0.53%323,927$153.87kInstitution
Blackrock Inc0.23%143,459$68.14kInstitution
Jon McGarity0.08%46,636$22.15kInsider

1 of 3

KLTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLTO1.59%16.11%
EVAX0.00%0.00%
DYAI6.29%93.71%Net Buying
IGC3.27%22.16%
BRNS18.17%53.40%

Klotho Neurosciences Stock Ownership FAQ

Who owns Klotho Neurosciences?

Klotho Neurosciences (NASDAQ: KLTO) is owned by 1.59% institutional shareholders, 16.11% Klotho Neurosciences insiders, and 82.30% retail investors. Joseph Sinkule is the largest individual Klotho Neurosciences shareholder, owning 4.85M shares representing 6.68% of the company. Joseph Sinkule's Klotho Neurosciences shares are currently valued at $2.26M.

If you're new to stock investing, here's how to buy Klotho Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.